TITLE: Proton Pump Inhibitor Cessation Programs: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines. DATE: 02 October 2014 . CONTEXT AND POLICY ISSUES Proton pump inhibitors (PPIs) are used to treat gastric or peptic ulcer, non-steroidal anti-

Outpatient use of Proton Pump Inhibitors . Clinical Practice Guideline . December 2017 "These guidelines are provided to assist physicians and other clinicians in making decisions regarding the care of their patients. They are not a substitute for individual judgment brought to each clinical situation by the patient's primary care provider in Proton pump inhibitors Overview Following endoscopic treatment of severe peptic ulcer bleeding, an intravenous, high-dose proton pump inhibitor reduces the risk of rebleeding and the need for surgery. Proton Pump Inhibitor De-prescribing Guidance Amendment History To review the use of Proton Pump Inhibitors (PPIs) prescribed by checking for appropriate licensed indication, dose National Institute for Health and Clinical Excellence Clinical Guideline 17. (October 2015). Dyspepsia: Managing Authors: Ray WA, Chung CP, Murray KT, et al. Citation: Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding. Proton pump inhibitors (PPIs) demonstrate gastric acid suppression superior to histamine-2 receptor antagonists (H 2RAs). PPIs achieve a more rapid and sustained increase in gastric pH The 2005 Guidelines for the Management of Dyspepsia state that in H. pylori-negative cases The first in a series of drug class-specific algorithms and guidelines issued by Dr Farrell's group is focused on proton pump inhibitors (PPIs). told Medscape why the guideline was needed and A proton pump is an integral membrane protein that builds up a proton gradient across a biological membrane. Proton pumps catalyze the following reaction: H + [on one side of a biological membrane] + energy ? H + [on th